AnalystsKaveri PohlmanKaveri Pohlman's Stock Forecasts
AnalystsKaveri Pohlman
Sectors:
Industries:
Analyst Ranking
Bottom 18%
#3797 out of 4566 analysts
Average Return
-1.18%
Win Rate
32%7 out of 22
Risk vs Reward
Poor
Good
Kaveri Pohlman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Checkmate Pharmaceuticals IncCMPI | +222.67% | $3.22 | $10.39 | 2022-03-30 - 2022-04-20 | Strong Buy |
Ambrx Biopharma IncAMAM | +137.69% | $11.78 | $28.00 | 2023-09-12 - 2024-03-06 | Strong Buy |
Macrogenics IncMGNX | +116.15% | $7.12 | $15.39 | 2023-03-21 - 2024-03-20 | Strong Buy |
Cytomx Therapeutics IncCTMX | +47.15% | $1.23 | $1.81 | 2022-07-07 - 2023-07-06 | Strong Buy |
Cullinan Therapeutics IncCGEM | +41.50% | $17.88 | $25.30 | 2024-04-17 - 2024-04-26 | Strong Buy |
Kaveri Pohlman Analyst Color
Get additional color on Kaveri Pohlman's coverage of popular stocks
Kaveri Pohlman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $30.00 | +18.58% | Maintains | 11 days ago |
Xencor IncXNCR | 1 | Strong Buy | $38.00 | +90.19% | Maintains | 12 days ago |
Nuvation Bio IncNUVB | 2 | Strong Buy | $5.00 | +86.57% | Upgrades | a month ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $62.00 | +30.83% | Initiates Coverage On | a month ago |
Macrogenics IncMGNX | 2 | Strong Buy | $24.00 | +64.84% | Maintains | 2 months ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $8.00 | +86.05% | Initiates Coverage On | 3 months ago |
Exelixis IncEXEL | 1 | Strong Buy | $27.00 | +13.92% | Initiates Coverage On | 4 months ago |
Genmab AGMAB | 2 | Strong Buy | $46.00 | +63.41% | Maintains | 6 months ago |
Ambrx Biopharma IncAMAM | 1 | Strong Buy | $26.00 | -7.14% | Initiates Coverage On | 8 months ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $70.00 | +350.16% | Reiterates | 8 months ago |
Oncosec Medical IncONCSQ | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Neximmune IncNEXI | 1 | Strong Buy | $125.00 | N/A | Initiates Coverage On | 2 years ago |
Checkmate Pharmaceuticals IncCMPI | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Oncternal Therapeutics IncONCT | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Sonnet Biotherapeutics Holdings IncSONN | 2 | Strong Buy | $616.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.